Rhythm Pharmaceuticals Netherlands B Vis A Subsidiary Of Rhythm Pharmaceuticals Internationalheadquartered In The Netherlandsincorporated In 2022The Company Operates In The Wholesale Trade Of Pharmaceutical Goods The Parent Company Focuses On Improving The Lives Of Patients And Families Affected By Hyperphagia And Severe Obesity Due To Rare Melanocortin 4 Receptormc4Rpathway Diseasesrhythm Pharmaceuticals Netherlands B Vhas Also Expanded Its Capabilities Through The Acquisition Of Xinvento Bva Biotech Firm Dedicated To Developing Therapies For Congenital Hyperinsulinisma Genetic Condition That Leads To Excessive Insulin Production
